Medtronic plc (MDT) Analysts See $1.38 EPS

May 18, 2018 - By John Moody

Medtronic plc (NYSE:MDT) LogoInvestors sentiment decreased to 1.02 in Q4 2017. Its down 0.10, from 1.12 in 2017Q3. It dived, as 65 investors sold Medtronic plc shares while 427 reduced holdings. 111 funds opened positions while 393 raised stakes. 1.04 billion shares or 2.98% less from 1.07 billion shares in 2017Q3 were reported.
680,045 are held by Cambiar Invsts Ltd Company. Moreover, Linscomb Williams has 0.16% invested in Medtronic plc (NYSE:MDT) for 24,097 shares. Dumont Blake Investment Advisors Limited has invested 0.4% in Medtronic plc (NYSE:MDT). 86,120 were reported by Amica Mutual Ins. Telemus Ltd Liability accumulated 0.06% or 8,993 shares. Moreover, City Communications has 0.66% invested in Medtronic plc (NYSE:MDT). Boston Family Office Ltd Liability Corp reported 0.08% stake. Jacobs Company Ca holds 0.64% or 44,552 shares in its portfolio. Strategic Financial Svcs reported 0.73% in Medtronic plc (NYSE:MDT). Arrowstreet Cap Ltd Partnership holds 0.52% in Medtronic plc (NYSE:MDT) or 2.69M shares. State Of New Jersey Common Pension Fund D has 1.35M shares. Farmers Fincl Bank holds 0.15% of its portfolio in Medtronic plc (NYSE:MDT) for 1,161 shares. Hermes Inv Mngmt Ltd invested 0.02% of its portfolio in Medtronic plc (NYSE:MDT). Moreover, Ssi Inv has 0.03% invested in Medtronic plc (NYSE:MDT) for 4,009 shares. Private Advisor Grp Limited Liability Company holds 23,536 shares or 0.08% of its portfolio.

Analysts expect Medtronic plc (NYSE:MDT) to report $1.38 EPS on May, 24 before the open.They anticipate $0.05 EPS change or 3.76 % from last quarter’s $1.33 EPS. MDT’s profit would be $1.87B giving it 15.42 P/E if the $1.38 EPS is correct. After having $1.17 EPS previously, Medtronic plc’s analysts see 17.95 % EPS growth. The stock decreased 0.51% or $0.44 during the last trading session, reaching $85.11. About 3.54M shares traded. Medtronic plc (NYSE:MDT) has declined 3.54% since May 18, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 10 analysts covering Medtronic (NYSE:MDT), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Medtronic had 12 analyst reports since November 21, 2017 according to SRatingsIntel. On Monday, February 5 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The firm earned “Buy” rating on Thursday, February 22 by Citigroup. The company was maintained on Tuesday, November 21 by Needham. Argus Research upgraded the stock to “Buy” rating in Tuesday, December 12 report. The rating was upgraded by Bank of America on Tuesday, January 2 to “Buy”. Morgan Stanley maintained Medtronic plc (NYSE:MDT) rating on Thursday, March 29. Morgan Stanley has “Equal-Weight” rating and $90 target. The rating was maintained by Stifel Nicolaus on Wednesday, November 22 with “Hold”. BMO Capital Markets maintained Medtronic plc (NYSE:MDT) on Tuesday, December 12 with “Buy” rating. On Friday, April 27 the stock rating was initiated by Piper Jaffray with “Buy”. The firm has “Buy” rating by Needham given on Wednesday, February 21.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company has market cap of $115.36 billion. The company's Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It has a 41.64 P/E ratio. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

More important recent Medtronic plc (NYSE:MDT) news were published by: which released: “Medtronic Should Focus On Aggressive Deleveraging” on May 15, 2018, also published article titled: “Mike Weinstein to Join Medtronic as Senior Vice President of Strategy”, published: “Medtronic Announces New Paid Family Care Leave Benefits” on May 01, 2018. More interesting news about Medtronic plc (NYSE:MDT) was released by: and their article: “Medtronic (MDT) Launches US Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients …” with publication date: May 16, 2018.

Medtronic plc (NYSE:MDT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: